Book contents
- Frontmatter
- Contents
- Advance Praise
- About the Editors
- List of Contributors
- Foreword
- Preface
- Prologue
- Section 1Administration
- Section 2Clinical Setting and Education
- Section 3New Developments
- Section 4Clinical
- Section 5Disasters Including Pandemics
- Section 6Financial
- Section 7Observation Medicine Regulations and Guidelines
- Section 8Observation Medicine Administration
- Section 9International
- Section 10Administrative Policies
- Section 11Protocols
- Section 12Order Sets
- Index
37 - Anticoagulants
from Subsection 4C - Clinical – Vascular
Published online by Cambridge University Press: 27 June 2025
Book contents
- Frontmatter
- Contents
- Advance Praise
- About the Editors
- List of Contributors
- Foreword
- Preface
- Prologue
- Section 1Administration
- Section 2Clinical Setting and Education
- Section 3New Developments
- Section 4Clinical
- Section 5Disasters Including Pandemics
- Section 6Financial
- Section 7Observation Medicine Regulations and Guidelines
- Section 8Observation Medicine Administration
- Section 9International
- Section 10Administrative Policies
- Section 11Protocols
- Section 12Order Sets
- Index
Summary
Oral anticoagulantion is used for the prevention and treatment of thromboembolism in patients with nonvalvular atrial fibrillation (NVAF), venous thromboembolism (VTE), mechanical heart valves, and other hypercoagulable states. In the past, warfarin was the predominant oral anticoagulant. Recently, direct oral anticoagulants (DOACs) have replaced warfarin as the preferred agents for the most common indications for oral anticoagulation: NVAF and VTE. The complication of anticoagulants is bleeding. Treatment including withholding the anticoagulant or administering medications to counteract the excessive anticoagulation and monitoring for further bleeding and/or the response to therapy can be done in the OU.
Information
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 210 - 218Publisher: Cambridge University PressPrint publication year: 2025
Accessibility standard: Inaccessible, or known limited accessibility
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.Accessibility Information
The PDF of this chapter is known to have missing or limited accessibility features. We may be reviewing its accessibility for future improvement, but final compliance is not yet assured and may be subject to legal exceptions. If you have any questions, please contact accessibility@cambridge.org.
Content Navigation
Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Reading Order & Textual Equivalents
Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Visual Accessibility
Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.